2012, Number 4
<< Back Next >>
Rev Med Inst Mex Seguro Soc 2012; 50 (4)
Reply to
Zambrano-Velarde MA, De la O-Peña D, Chávez-Peña Q, Bedolla-Barajas M
Language: Spanish
References: 5
Page: 353-354
PDF size: 56.02 Kb.
Text Extraction
No Abstract
REFERENCES
Panchal S, Khare M, Moorthy A, Samanta A. Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy. Rheumatol Int 2012 Mar 27.
Ton E, Tekstra J, Hellmann PM, Nuver-Zwart IH, Bijlsma JW. Safety of rituximab therapy during twins’ pregnancy. Rheumatology (Oxford) 2011;50(4):806-808.
Chambers C, Koren G, Tutuncu ZN, Johnson D, Jones KL. Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study. Can Fam Physician 2007;53(3):409-412. Disponible en http://www.ncbi. nlm.nih.gov/pmc/articles/PMC1949070/
Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum 2009;61(5):587-592. Disponible en http://onlinelibrary.wiley.com/doi/10.1002/ art.24462/abstract;jsessionid=4D184B827E4032EDE0B 8FCAD522A1E3E.d03t03
Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011;117(5):1499-1506. Disponible en http:// bloodjournal.hematologylibrary.org/content/117/5/1499. long
Full text